PALISADE BIO, INC. Basic Shares Outstanding (Weighted Average)
PALISADE BIO, INC. (PALI) reported Basic Shares Outstanding (Weighted Average) of 211.38 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- PALISADE BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 211.38M shares, a 4306.37% increase year-over-year.
- PALISADE BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 209.66M shares, a 4271.97% increase year-over-year.
- PALISADE BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 205.57M shares, a 9412.64% increase year-over-year.
- PALISADE BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 7.47M shares, a 398.12% increase year-over-year.
- PALISADE BIO, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 55.67M shares, a 3830.18% increase from fiscal 2024.
- PALISADE BIO, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 1.42M shares, a 210.62% increase from fiscal 2023.
- PALISADE BIO, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 456.01K shares, a 48.20% decline from fiscal 2022.
- PALISADE BIO, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 880.31K shares, a 372.79% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 211.38M shares 10-Q · filed 2026-08-10 | 210.53M shares 10-Q · filed 2026-08-10 | 208.87M shares derived: average of 3 quarters · filed 2026-08-10 | 158.52M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | 209.66M shares 10-Q · filed 2026-05-12 | 207.62M shares derived: average of 2 quarters · filed 2026-05-12 | 140.90M shares derived: average of 3 quarters · filed 2026-05-12 | 106.88M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | 205.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | 106.52M shares derived: average of 2 quarters · filed 2026-03-20 | 72.61M shares derived: average of 3 quarters · filed 2026-08-10 | 55.67M shares 10-K · filed 2026-03-20 | ||||
| 2025-09-30 | 7.47M shares 10-Q · filed 2025-11-10 | 6.14M shares derived: average of 2 quarters · filed 2026-08-10 | 5.70M shares 10-Q · filed 2025-11-10 | 4.81M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | 4.80M shares 10-Q · filed 2026-08-10 | 4.80M shares 10-Q · filed 2026-08-10 | 3.92M shares derived: average of 3 quarters · filed 2026-08-10 | 3.31M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | 4.80M shares 10-Q · filed 2026-05-12 | 3.48M shares derived: average of 2 quarters · filed 2026-05-12 | 2.82M shares derived: average of 3 quarters · filed 2026-05-12 | 2.42M shares derived: average of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | 2.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | 1.83M shares derived: average of 2 quarters · filed 2026-03-20 | 1.63M shares derived: average of 3 quarters · filed 2026-03-20 | 1.42M shares 10-K · filed 2026-03-20 | ||||
| 2024-09-30 | 1.50M shares 10-Q · filed 2025-11-10 | 1.36M shares derived: average of 2 quarters · filed 2025-11-10 | 1.17M shares 10-Q · filed 2025-11-10 | 1.03M shares derived: average of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | 1.23M shares 10-Q · filed 2025-08-11 | 1.00M shares 10-Q · filed 2025-08-11 | 871.47K shares derived: average of 3 quarters · filed 2025-08-11 | 776.01K shares derived: average of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | 768.14K shares 10-Q · filed 2025-05-12 | 692.99K shares derived: average of 2 quarters · filed 2025-05-12 | 625.20K shares derived: average of 3 quarters · filed 2025-05-12 | 575.86K shares derived: average of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | 617.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 553.73K shares derived: average of 2 quarters · filed 2025-03-24 | 511.77K shares derived: average of 3 quarters · filed 2025-03-24 | 456.01K shares 10-K · filed 2025-03-24 | 6.84M shares 10-K · filed 2024-03-26 | |||
| 2023-09-30 | 489.62K shares 10-Q · filed 2024-11-12 | 7.34M shares 10-Q · filed 2023-11-09 | 458.74K shares derived: average of 2 quarters · filed 2024-11-12 | 402.07K shares 10-Q · filed 2024-11-12 | 6.03M shares 10-Q · filed 2023-11-09 | 752.10K shares derived: average of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | 427.86K shares 10-Q · filed 2024-08-12 | 6.42M shares 10-Q · filed 2023-08-10 | 357.57K shares 10-Q · filed 2024-08-12 | 5.36M shares 10-Q · filed 2023-08-10 | 839.59K shares derived: average of 3 quarters · filed 2024-08-12 | 873.24K shares derived: average of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | 287.70K shares 10-Q · filed 2024-05-13 | 4.32M shares 10-Q · filed 2023-05-11 | 1.05M shares derived: average of 2 quarters · filed 2024-05-13 | 1.02M shares derived: average of 3 quarters · filed 2024-05-13 | 867.75K shares derived: average of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | 1.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | 1.39M shares derived: average of 2 quarters · filed 2024-03-26 | 1.06M shares derived: average of 3 quarters · filed 2024-03-26 | 880.31K shares 10-K · filed 2024-03-26 | ||||
| 2022-09-30 | 974.20K shares 10-Q · filed 2023-11-09 | 48.71M shares 10-Q · filed 2022-11-14 | 690.04K shares derived: average of 2 quarters · filed 2023-11-09 | 572.68K shares 10-Q · filed 2023-11-09 | 28.63M shares 10-Q · filed 2022-11-14 | -5.31M shares derived: average of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | 405.89K shares 10-Q · filed 2023-08-10 | 20.29M shares 10-Q · filed 2022-08-15 | 365.63K shares 10-Q · filed 2023-08-10 | 18.28M shares 10-Q · filed 2022-08-15 | -7.41M shares derived: average of 3 quarters · filed 2023-08-10 | -2.53M shares derived: average of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | 324.47K shares 10-Q · filed 2023-05-11 | -11.32M shares derived: average of 2 quarters · filed 2023-05-11 | -3.51M shares derived: average of 3 quarters · filed 2023-05-11 | -426.31K shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -22.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -5.43M shares derived: average of 2 quarters · filed 2023-03-22 | -676.57K shares derived: average of 3 quarters · filed 2023-03-22 | 186.19K shares 10-K · filed 2023-03-22 | 9.31M shares 10-K · filed 2022-03-17 | |||
| 2021-09-30 | 12.10M shares 10-Q · filed 2022-11-14 | 10.47M shares derived: average of 2 quarters · filed 2022-11-14 | 7.90M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 8.83M shares 10-Q · filed 2022-08-15 | 5.80M shares 10-Q · filed 2022-08-15 | ||||||
| 2020-12-31 | 2.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 2.77M shares derived: average of 2 quarters · filed 2022-03-17 | 2.77M shares derived: average of 3 quarters · filed 2022-03-17 | 2.77M shares 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | 2.77M shares 10-Q · filed 2021-11-12 | 2.77M shares derived: average of 2 quarters · filed 2021-11-12 | 2.77M shares 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | 2.77M shares 10-Q · filed 2021-08-23 | 2.77M shares 10-Q · filed 2021-08-23 | ||||||
| 2018-09-30 | 15.17M shares 10-Q · filed 2018-11-14 | 15.14M shares 10-Q · filed 2018-11-14 | ||||||
| 2017-09-30 | 14.06M shares 10-Q · filed 2018-11-14 | 12.38M shares 10-Q · filed 2018-11-14 | ||||||
| 2016-09-30 | 8.84M shares 10-Q · filed 2017-11-08 | 8.02M shares 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |